← Back to headlines
Guggenheim Maintains Investment Ratings on Summit Therapeutics and Dick’s Sporting Goods
Guggenheim Securities has reaffirmed its investment ratings for both Summit Therapeutics and Dick’s Sporting Goods, citing recent clinical trial developments and standard market evaluations.
26 Aug, 11:58 — 26 Aug, 11:58
Sources
Showing 1 of 1 sources
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
1h ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago